Hitoshi Yagisawa
Akita, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Risk factors for hepatocellular carcinoma at baseline and 1 year after initiation of nucleos(t)ide analog therapy for chronic hepatitis B.
Journal: Journal of medical virology
Published: May 22, 2022
A validation study of after direct-acting antivirals recommendation for surveillance score for the development of hepatocellular carcinoma in patients with hepatitis C virus infection who had received direct-acting antiviral therapy and achieved sustained virological response.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: November 08, 2021
Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus.
Journal: Hepatology communications
Published: October 22, 2021
Real-world clinical outcomes of sofosbuvir and velpatasvir treatment in HCV genotype 1- and 2-infected patients with decompensated cirrhosis: A nationwide multicenter study by the Japanese Red Cross Liver Study Group.
Journal: Journal of medical virology
Published: June 13, 2021
Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 15, 2020
Detectable HBV DNA during nucleos(t)ide analogues stratifies predictive hepatocellular carcinoma risk score.
Journal: Scientific reports
Published: January 21, 2020
Real-world efficacy of elbasvir and grazoprevir for hepatitis C virus (genotype 1): A nationwide, multicenter study by the Japanese Red Cross Hospital Liver Study Group.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: January 15, 2019
Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group.
Journal: Journal of gastroenterology
Published: January 14, 2018
Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysis.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: November 07, 2017
One year of infliximab therapy successfully improved a case of refractory pouchitis without the use of antibiotics.
Journal: Internal medicine (Tokyo, Japan)
Published: November 18, 2014
Ulcerative colitis accompanied by idiopathic thrombocytopenic purpura and Helicobacter pylori infection.
Journal: Internal medicine (Tokyo, Japan)
Published: March 02, 2013
Last Updated: 09/26/2026